22213745 Muscular Dystrophy

Embed Size (px)

Citation preview

  • 8/14/2019 22213745 Muscular Dystrophy

    1/40

    Muscular Dystrophies

    Lhedaven C. Santos R.N.

  • 8/14/2019 22213745 Muscular Dystrophy

    2/40

    Muscular Dystrophies

    Progressive hereditary degenerative diseases of the skeletal muscle

    Intact spinal motor neurons, muscular nerves, and nerve endings in

    the presence of severe degenerative changes in muscle fibers

    General features:

    symmetrical distribution of weakness and atrophy

    intact sensation

    preservation of reflexes

    heredofamilial

    Classified by clinical types, pattern of inheritance and by the

    abnormal gene or its protein product

  • 8/14/2019 22213745 Muscular Dystrophy

    3/40

    Etiology The abnormal gene and the gene product for Duchenne and

    Becker identified by Kunkel in 1986

    Dystrophin is the protein encoded by the affected gene

    Dystrophin absent in Duchenne and structurally abnormal in

    Becker

    Dystrophin in normal skeletal and cardiac muscle is localized in

    the sarcolemma (cytoplasmic site) and interacts with F-actin of

    the cytoskeleton (reinforcing structure of muscle cell)

    Dystrophin also bound to a complex of sarcolemmal proteinsknown as dystrophin associated proteins (DAP)

  • 8/14/2019 22213745 Muscular Dystrophy

    4/40

    Etiology

    Loss of dystrophin leads to disruption of the

    dystroglycan-protein complex rendering the

    sarcolemma susceptible to breaks duringcontraction

    These defects are shown to allow ingress of

    EC fluid and calcium which activateproteases and cause protein degradation

    Leakage of CK into serum is then seen

  • 8/14/2019 22213745 Muscular Dystrophy

    5/40

  • 8/14/2019 22213745 Muscular Dystrophy

    6/40

    Duchenne MD

    Incidence rate 13-33 per 100,000 male births annually

    X-linked recessive

    30% of cases represent new mutations

    Females can present disease if only one chromosome is present

    (Turner) or due to inactivation of the normal paternal X

    chromosome in large proportion of embryonic cells (decreased

    expression of the normal dystrophin allele)

  • 8/14/2019 22213745 Muscular Dystrophy

    7/40

    Clinical findings

    Recognized usually in third year of life due to delay

    in motor milestones or due to frequent falls

    Latter sway back and waddling gait (weak gluteus

    medius) as well as climbing stairs become more

    affected

    Elevated CK may be the first clue

  • 8/14/2019 22213745 Muscular Dystrophy

    8/40

    Clinical findings

    Muscles mostly affected

    early: illiopsoas, quadriceps, gluteal

    latter: pretibial, pectoral girdle (serratus, pectorals,latissimus) and upper limbs (biceps, brachioradialis)

    Muscles pseudo-hypertrophied

    gastronemius, lateral vastus and deltoid

    have rubbery feel and are less strong and hypotonic

    than normals

  • 8/14/2019 22213745 Muscular Dystrophy

    9/40

    Clinical findings

    Weakness of abdominal and paravertebral muscles

    - lordotic posture and protuberant abdomen when

    standing and rounded back when sitting Weak extensors of the knee and hip - difficult to

    climb stairs or from a chair

    Use of hands to compensate for weakness when

    rising from sitting position or from floor

  • 8/14/2019 22213745 Muscular Dystrophy

    10/40

  • 8/14/2019 22213745 Muscular Dystrophy

    11/40

    Gowers maneuver

    4 point position

    Hands up to thigh

    alternately

  • 8/14/2019 22213745 Muscular Dystrophy

    12/40

    Clinical Findings

    Ocular, facial and bulbar and hand muscles are usually

    spared

    Limbs later become flaccid but as disability progresses

    fibrous contractures appear due to immobility

    Early in the disease there is equinovarus due to weak

    pretibial and peroneal muscles; later knee contractures

    appear due to weak quadriceps

    Pelvic tilt also seen later due to contracture of hip flexors

    this is compensated with lordosis when standing

  • 8/14/2019 22213745 Muscular Dystrophy

    13/40

  • 8/14/2019 22213745 Muscular Dystrophy

    14/40

    Clinical Findings

    Contractures contribute to eventual loss of ambulation

    Scoliosis appears due to unequal weakening of paravertebral

    muscles usually after walking is not possible

    As muscle atrophy progresses DTRs are lost

    Bones are thin and demineralized

    Can have mild mental retardation

    Although smooth muscle is usually spared heart is usuallyaffected

  • 8/14/2019 22213745 Muscular Dystrophy

    15/40

    Clinical Findings

    Cardiac problems:

    Arrhythmias

    prominent R waves in right precordial leads and deep Q waves in

    left precordial and limb leads as result of replacement fibrosis of the

    basal part of the left ventricular wall

    Death is usually 2dary to pulmonary infection and respiratory

    failure or in some due to cardiac decompensation

    No more than 25% of patients survive beyond 25 years

  • 8/14/2019 22213745 Muscular Dystrophy

    16/40

    Muscle biopsy

    In all dystrophies loss of

    muscle fibers, residual fibers of

    small and larger size in

    haphazard arrangement andincrease in lipocytes and

    fibrosis

    Duchenne -Early: segmental degeneration,

    phagocytosis and evidence of regenerative

    activity

    basophilia of sarcoplasm

    hyperplasia and nucleolation of sarcolemmal

    nuclei

    myotubes and myocytes

    Necrotic sarcoplasm and sarcolemma

    removed by mononuclear cells

    Hyalinization of the sarcoplasm of muscle

    fibers as marker of irritability of m fiber

    Fibers eventually degenerate and disappeardue to exhaustion of regenerative capacity

  • 8/14/2019 22213745 Muscular Dystrophy

    17/40

  • 8/14/2019 22213745 Muscular Dystrophy

    18/40

  • 8/14/2019 22213745 Muscular Dystrophy

    19/40

    Becker Muscular Dystrophy

    Incidence estimated to be 3-6 per 100,000 male births

    X-linked disorder

    Later onset than Duchenne (mean age 12 years but range 5-45 y/o)

    Affects same muscles as Duchennes MD Patient non-ambulatory at 25-30 y/o

    Death in 5th decade in most

    Less frequent cardiac involvement

    Serum CK 25-200 times normal

    EMG: fibrillations, positive waves, low amplitude polyphasic MUP

  • 8/14/2019 22213745 Muscular Dystrophy

    20/40

    Facioscapulohumeral MD Slowly progressive or nearly complete arrest

    Usually autosomal dominant 4 q35

    Subvariety w/o facial weakness

    Onset usually 6-20 y/o Difficulty raising arms above head and winging of the

    scapulae first manifestations

    Invariably weakness of lower trapezius and sternal part of

    pectoralis

    Deltoids unusually large and strong

    Weak orbicularis oculi and oris,zygomaticus

  • 8/14/2019 22213745 Muscular Dystrophy

    21/40

    Facioscapulohumeral MD

    Eventually atrophy involves sternomastoid, serratus,

    rhomboid, erector spinae, latissimus and deltoids

    Winged and elevated scapulae, prominent clavicles

    Popeye arm: upper arm thinner than forearm

    Pelvic muscles involved later and milder

    Can be asymmetrical

    CPK can be normal or mildly elevated Rare cardiac involvement

  • 8/14/2019 22213745 Muscular Dystrophy

    22/40

    Scapular winging

    Weak (serratus, lower

    trapezius, rhomboids)

    stabilizers of scapulacause winging

    Scapular angles can be

    seen when facing the

    patient

  • 8/14/2019 22213745 Muscular Dystrophy

    23/40

  • 8/14/2019 22213745 Muscular Dystrophy

    24/40

    Facioscapulohumeral MD

    Foot drop might be seen

    Early in the disease weakness can be

    asymmetrical

    Rare cardiac involvement

    CPK normal or slightly elevated

  • 8/14/2019 22213745 Muscular Dystrophy

    25/40

  • 8/14/2019 22213745 Muscular Dystrophy

    26/40

  • 8/14/2019 22213745 Muscular Dystrophy

    27/40

    Scapuloperoneal MD

    Autosomal dominant, Chromosome 12

    Typically involves muscles of the neck, shoulder,

    upper arms, anterior tibial and peroneal groups Onset usually in early or middle adulthood

    Walking becomes difficult due to foot drop

    Symptoms in arms and shoulders usually seen later

    Progression slow in most cases

  • 8/14/2019 22213745 Muscular Dystrophy

    28/40

  • 8/14/2019 22213745 Muscular Dystrophy

    29/40

    Limb-girdle MD

    Heterogeneous group Children of both sexes affected

    No hypertrophy (besides SCARMD)

    Adults can have weakness in either pelvic or shoulder girdle

    or both, if later onset more benign course Most commonly heredited as autosomal recessive (2A-2J),

    Also AD (1A-1E) forms, AD good prognosis

    EMG myopathic, CK normal or only moderately elevated,

    cardiac involvement infrequent

  • 8/14/2019 22213745 Muscular Dystrophy

    30/40

  • 8/14/2019 22213745 Muscular Dystrophy

    31/40

    AD Limb Girdle Dystrophies

    LGMD 1 Onset is varied from 4-38 years

    CPK is slightly or moderately increased

    Can have flexion contractures of elbows, ankles, and IPJ

    but non-disabling

    Slow progression with long periods of arrest

    Normal longevity

    Some with facial and cardiac involvement

    Includes defects in proteins located in myofibril, cell

    membrane and EC (collagen proteins)

  • 8/14/2019 22213745 Muscular Dystrophy

    32/40

    AR Limb Girdle Dystrophies

    LGMD 2

    Affects males and females equally

    Shoulder and pelvic girdles affected

    Defects in proteins located on cell membranes but also on

    myofibril+nucleus (calpain 3)

    SCARMD (2C-2F)- clinically similar to DMB, from 3-12 y/o onset,

    CPK 10-100 times normal, hypertrophy and joint contractures, rare

    cardio involvement

    Some have involvement of distal lower extremities (dysferlinopathy)

  • 8/14/2019 22213745 Muscular Dystrophy

    33/40

  • 8/14/2019 22213745 Muscular Dystrophy

    34/40

  • 8/14/2019 22213745 Muscular Dystrophy

    35/40

    Severe Childhood AR Muscular

    Dystrophy (SCARMD) LGMD 2C -2E

    Calf hypertrophy

    Cardiac involvement

    marked elevations of CPK early

    Defect is in one of the 3 dystrophin associated glycoproteins

    sarcoglycan, chr 13q

    sarcoglycan is called adhalin, chr 17q21

    sarcoglycan also called hetarosin , chr 4q12

  • 8/14/2019 22213745 Muscular Dystrophy

    36/40

    AD Limb-Girdle Dystrophy with

    cardiac conduction involvement Mild proximal limb/girdle dystrophy

    In half cases cardiac conduction disorders being

    the major threat to life Begins in Lext then shoulders

    CK normal or moderately elevated

    All patients retain ambulation Mild contratures infrequent

    Pacemaker required in some old patients

  • 8/14/2019 22213745 Muscular Dystrophy

    37/40

    Emery- Dreifuss Muscular

    Dystrophy X-linked, chromosome Xq28 -emerin

    Age of onset: childhood- adulthood

    Weakness first upper arm and pectoral girdle; later pelvic girdle

    and distal muscles in Lexts

    Early appearance of contractures in elbow flexors, extensors of the

    neck and posterior calf muscles

    No pseudohypertrophy

    Usually accompanied by severe cardiomyopathy with variable s/aand a/v conduction defects

    Death secondary to cardiac problems although general course is

    benign in most

  • 8/14/2019 22213745 Muscular Dystrophy

    38/40

  • 8/14/2019 22213745 Muscular Dystrophy

    39/40

    Oculopharyngeal Dystrophy

    Autosomal dominant; chr 14q11.2-14q13

    Usually late onset (after 45th y/o)

    Bilateral ptosis and dysphagia noticed as progressive

    difficulty in swallowing and change in voice, can

    progress to cachexia

    External ocular muscles, shoulder and pelvic muscles

    can later become weak CK and aldolase might be normal

    EMG only altered in the affected muscle

  • 8/14/2019 22213745 Muscular Dystrophy

    40/40

    LGMD